Experts share here what they take away from the Conference on Retroviruses and Opportunistic Infections (CROI) each year and why this meeting is so important in this space. The combination of ...

In a first-ever milestone, Africa’s initial HIV cure trial has yielded historic findings: 20% of patients have remained off antiretroviral therapy (ART) for over a year and a half and have the virus ...

based on this latest study presented at the Conference of Retroviruses and Opportunistic Infections. (The study has not yet been published in a peer-reviewed journal.) Researchers studied more ...

This study that evaluates an annual injection of a pre-exposure prophylaxis medication for HIV has been published in The Lancet and presented simultaneously at the Conference on Retroviruses and ...

SAN FRANCISCO — During the opening day of the Conference on Retroviruses and Opportunistic Infections, Rebecca Denison, a decades-long HIV survivor, addressed conference attendees and discussed ...

The phase 2 study – reported at the Conference on Retroviruses and Opportunistic Infections (CROI) in Denver, Colorado – looked at the combination of MSD’s experimental long-acting reverse ...

The CDC has terminated an advisory committee responsible for providing federal guidance on the prevention and control of health care-associated infections ... at the Conference on Retroviruses ...